Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-03

Clinical Trial Update: Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) [NA]

View source ↗

Summary

A clinical trial update indicates that electroconvulsive therapy is being studied for agitation in Alzheimer's disease, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Electroconvulsive therapy

Snippet

Sponsor: Brent Forester | Conditions: Alzheimer Dementia, Agitation,Psychomotor | NA | Status: RECRUITING